ALXO · Categories · Form 4

ALXO - SEC Form 4 insider transactions

ALX Oncology Holdings Inc. (ALXO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ALXO

• 47d
  SEC Form 4 filed by Knight Jeff E.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 47d
  SEC Form 4 filed by Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 72d
  SEC Form 4 filed by Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 72d
  SEC Form 4 filed by Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 90d
  SEC Form 4 filed by Chief Medical Officer Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 103d
  SVP, FINANCE AND CAO Pinto Shelly sold $1,283 worth of shares (565 units at $2.27), decreasing direct ownership by 0.64% to 87,708 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 103d
  CHIEF EXECUTIVE OFFICER Lettmann Jason covered exercise/tax liability with 2,201 shares, decreasing direct ownership by 0.71% to 305,920 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 126d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 126d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 126d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Goodman Corey S

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Garland J. Scott

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Takimoto Chris H

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 133d
  SEC Form 4 filed by Director Curran Daniel J.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 147d
  SVP, FINANCE AND CAO Pinto Shelly sold $4,357 worth of shares (3,925 units at $1.11), decreasing direct ownership by 4% to 88,273 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 230d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 230d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 230d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 257d
  SEC Form 4 filed by Director Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 288d
  SVP, FINANCE AND CAO Pinto Shelly sold $391 worth of shares (611 units at $0.64), decreasing direct ownership by 0.68% to 89,198 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 288d
  CHIEF EXECUTIVE OFFICER Lettmann Jason sold $1,525 worth of shares (2,382 units at $0.64), decreasing direct ownership by 1% to 212,888 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 294d
  SEC Form 4 filed by Director Curran Daniel J.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 330d
  SVP, FINANCE AND CAO Pinto Shelly sold $905 worth of shares (2,011 units at $0.45), decreasing direct ownership by 2% to 86,809 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 337d
  SVP, FINANCE AND CAO Pinto Shelly sold $659 worth of shares (1,532 units at $0.43), decreasing direct ownership by 2% to 88,820 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 414d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 414d
  SEC Form 4 filed by Chief Medical Officer Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 414d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 414d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 442d
  SVP, FINANCE AND CAO Pinto Shelly was granted 3,000 shares, increasing direct ownership by 3% to 90,352 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 442d
  CHIEF EXECUTIVE OFFICER Lettmann Jason was granted 42,000 shares, increasing direct ownership by 25% to 212,270 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 467d
  SVP, FINANCE AND CAO Pinto Shelly sold $633 worth of shares (550 units at $1.15), decreasing direct ownership by 0.63% to 87,352 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 467d
  PRESIDENT & CSO Pons Jaume sold $1,525 worth of shares (1,326 units at $1.15), decreasing direct ownership by 0.23% to 579,388 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 467d
  CHIEF EXECUTIVE OFFICER Lettmann Jason sold $2,483 worth of shares (2,159 units at $1.15), decreasing direct ownership by 1% to 170,270 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Director Hemrajani Rekha

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Director Garland J. Scott

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Director Goodman Corey S

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Director Takimoto Chris H

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Director Klencke Barbara

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Chief Financial Officer Shantharam Harish

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by SVP, FINANCE AND CAO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by Chief Medical Officer Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by PRESIDENT & CSO Pons Jaume

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 495d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 511d
  Interim CFO Pinto Shelly sold $3,998 worth of shares (2,221 units at $1.80), decreasing direct ownership by 2% to 87,902 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 517d
  Interim CFO Pinto Shelly sold $2,253 worth of shares (1,426 units at $1.58), decreasing direct ownership by 2% to 90,123 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 517d
  PRESIDENT & CSO Pons Jaume sold $17,060 worth of shares (10,796 units at $1.58), decreasing direct ownership by 2% to 580,714 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 546d
  SEC Form 4 filed by Interim CFO Pinto Shelly

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 546d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lettmann Jason

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 561d
  SEC Form 4 filed by Chief Medical Officer Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 656d
  SVP, FINANCE AND CAO Pinto Shelly sold $1,455 worth of shares (564 units at $2.58), decreasing direct ownership by 0.61% to 91,549 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 656d
  CHIEF MEDICAL OFFICER Randolph Sophia sold $3,522 worth of shares (1,365 units at $2.58), decreasing direct ownership by 0.42% to 325,711 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 656d
  CHIEF FINANCIAL OFFICER Garcia Peter S covered exercise/tax liability with 761 shares, decreasing direct ownership by 0.62% to 121,516 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 656d
  PRESIDENT & CSO Pons Jaume sold $4,997 worth of shares (1,937 units at $2.58), decreasing direct ownership by 0.33% to 591,510 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 656d
  CHIEF EXECUTIVE OFFICER Lettmann Jason covered exercise/tax liability with 2,191 shares, decreasing direct ownership by 1% to 169,429 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 665d
  SEC Form 4 filed by Director Sandler Alan B.

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 688d
  PRESIDENT & CSO Pons Jaume exercised 20,000 shares at a strike of $0.99 and sold $158,076 worth of shares (20,000 units at $7.90) (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 694d
  SVP, FINANCE AND CAO Pinto Shelly sold $10,025 worth of shares (1,823 units at $5.50), decreasing direct ownership by 2% to 92,113 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)
• 700d
  SVP, FINANCE AND CAO Pinto Shelly sold $7,989 worth of shares (1,373 units at $5.82), decreasing direct ownership by 1% to 93,936 units (SEC Form 4)

  4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

Other ALXO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends